Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

NCT04000698 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Refractory Acute Myeloid Leukemia
Refractory Acute Lymphoblastic Leukemia

Interventions

DRUG: Preparative regimen

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology